Cargando…
ZFP36 Inhibits Tumor Progression of Human Prostate Cancer by Targeting CDK6 and Oxidative Stress
BACKGROUND: The expression of ZFP36 in previous study was reduced in prostate cancer (PCa) tissues as compared to benign prostate tissues, indicating the potential of ZFP36 as an auxiliary marker for PCa. Further evaluation was conducted in clinical samples for in vitro and in vivo experiments, to p...
Autores principales: | Yuan, Dongbo, Fang, Yinyi, Chen, Weiming, Jiang, Kehua, Zhu, Guohua, Wang, Wei, Zhang, Wei, You, Ganhua, Jia, Zhenyu, Zhu, Jianguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470309/ https://www.ncbi.nlm.nih.gov/pubmed/36111167 http://dx.doi.org/10.1155/2022/3611540 |
Ejemplares similares
-
Retracted: ZFP36 Inhibits Tumor Progression of Human Prostate Cancer by Targeting CDK6 and Oxidative Stress
por: Longevity, Oxidative Medicine and Cellular
Publicado: (2023) -
ZFP36L1 promotes monocyte/macrophage differentiation by repressing CDK6
por: Chen, Ming-Tai, et al.
Publicado: (2015) -
The RNA-binding proteins Zfp36l1 and Zfp36l2 act redundantly in myogenesis
por: Bye-A-Jee, Hema, et al.
Publicado: (2018) -
ZFP36L1 and ZFP36L2 control LDLR mRNA stability via the ERK–RSK pathway
por: Adachi, Shungo, et al.
Publicado: (2014) -
Functional regulation of Zfp36l1 and Zfp36l2 in response to lipopolysaccharide in mouse RAW264.7 macrophages
por: Wang, Kuan-Ting, et al.
Publicado: (2015)